Arvinas to present ARV-102 Parkinson's trial data at MDS congress

October 1, 2026 4:01 PM

Arvinas, Inc. (Nasdaq: ARVN) said it will present biomarker data from a Phase 1 clinical trial of its investigational drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found